EUIPO trademark

GeneStrat

RegisteredEUIPOWord markClass 42Class 44

"GeneStrat" is a word mark owned by Biodesix, Inc., filed at the EUIPO on September 12, 2016. It is registered and covers classes 42 and 44.

View Biodesix, Inc. portfolioGet this data via the API
Official EUIPO record
GeneStrat
Word mark as filed with the EUIPO
Status
Registered
Filed
September 12, 2016
Registered
March 13, 2017
Expires
September 12, 2036
Application no.
015821473
Registration no.
015821473
Office
EUIPO
European Union Intellectual Property Office
Mark type
Word mark
2 classes
Ownership

Who owns GeneStrat

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Biodesix, Inc.

BDSX

68 trademarks in the portfolioView company

Representative

CSY Europe

Goods and services

What the mark covers

The products and services GeneStrat is filed for, grouped by Nice class.

  • Research services relating to medical diagnosis; Laboratory testing services; Laboratory services relating to medical diagnosis and to medical treatment; Analytical laboratory services; laboratory services for preparation, detection, quantitation, and analysis of biological material, for genotyping, for diagnostic assays, and for carrying out nucleic acid sequencing reactions; Research services related to developing prognostic and predictive tests to determine whether patients or a subgroup of patients are likely to benefit from treatment with therapies or combination of therapies intended to treat a disease or disorder, including anti-cancer drugs for cancer; Design and development of computer hardware and software; Providing information regarding tests via an interactive website

  • Medical services for the diagnosis of conditions of the human body; Performing diagnosis of diseases; Commercial genomic testing services provided from a central laboratory ordered by oncologists to determine which cancer patients may have better outcomes on or benefit from treatments; information services relating to prediction of likely patient benefit from therapeutic treatment, including anti-cancer drugs for cancer

History

What has happened so far

Steps recorded by the EUIPO, newest first.

  1. Bulletin 2026/136 Section D.1
  2. Bulletin 2025/112 Section C.1.3
  3. Bulletin 2025/107 Section C.2.2
  4. Bulletin 2022/222 Section C.2.2
  5. Bulletin 2021/011 Section C.2.2
  6. Bulletin 2020/231 Section C.2.2
  7. Bulletin 2020/222 Section C.2.2
  8. Bulletin 2019/219 Section C.2.1
  9. Bulletin 2017/051 Section B.1
  10. Bulletin 2016/229 Section A.1
FAQ

About GeneStrat

Who owns the trademark "GeneStrat"?

The EUIPO trademark "GeneStrat" (application 015821473) is owned by Biodesix, Inc.

What is the status of "GeneStrat"?

Its status at the EUIPO is: registered.

When was "GeneStrat" registered?

It was registered on March 13, 2017 and is due to expire on September 12, 2036.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull GeneStrat and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d48ff-78a5-7384-b561-3aad3ca59431
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d48ff-78a5-7384-b561-3aad3ca59431",
  "object": "trademark",
  "mark_text": "GeneStrat",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "EM",
  "application_number": "015821473",
  "filing_date": "2016-09-12",
  "nice_classes": [
    42,
    44
  ],
  "owners": [
    {
      "name": "Biodesix, Inc.",
      "entity_id": "ent_019ebba6-a4ee-73e2-a05e-bb8ed3bb637d"
    }
  ]
}